In a stable adult without unstable angina, recent myocardial infarction, left ventricular dysfunction, or extensive multivessel disease who has an intermediate (≈40‑70 % diameter) left main coronary artery stenosis, can fractional flow reserve be used to guide revascularisation, and what FFR cutoff indicates the need for intervention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

FFR-Guided Management of Intermediate Left Main Coronary Artery Stenosis

Yes, FFR can and should be used to guide revascularization decisions in intermediate left main stenosis, with an FFR ≤0.80 indicating the need for intervention (typically CABG), while FFR >0.80 supports deferral of revascularization with medical management. 1, 2

FFR Cutoff Values for Left Main Disease

The established FFR threshold for intervention is ≤0.80, which represents the standard cutoff used in contemporary clinical practice and trials. 2 This cutoff was selected to increase sensitivity for detecting functionally significant stenoses, though the original ischemic threshold was established at 0.75. 2

The Gray Zone (0.75-0.80)

  • A "gray zone" exists between FFR values of 0.75-0.80, affecting approximately 10% of measurements. 2
  • Patients with borderline FFR values (0.81-0.85) have higher rates of subsequent intervention—approximately one in four stenoses in this range required revascularization during follow-up. 1
  • Clinical events increase as FFR decreases, with lower FFR values (even within the "normal" range) associated with worse outcomes compared to near-normal values. 1

Clinical Evidence Supporting FFR in Left Main Disease

Long-term outcomes data specifically for left main stenosis demonstrate the safety and efficacy of FFR-guided management:

  • In 213 patients with angiographically equivocal left main stenosis, FFR-guided strategy showed 5-year survival of 89.8% in the nonsurgical group (FFR ≥0.80) versus 85.4% in the surgical group (FFR <0.80), with no significant difference (P=0.48). 3
  • Event-free survival at 5 years was 74.2% versus 82.8% in nonsurgical and surgical groups respectively (P=0.50), demonstrating that deferral based on FFR >0.80 is safe. 3

Angiography Alone is Inadequate

Angiographic assessment of left main stenosis severity correlates poorly with functional significance:

  • Percent diameter stenosis by quantitative coronary angiography showed only weak correlation with FFR (r=-0.38, P<0.001) with very large scatter. 3
  • In 23% of patients with diameter stenosis <50% by angiography, the left main stenosis was hemodynamically significant by FFR. 3
  • This discordance means angiography alone does not allow appropriate individual decision-making and often underestimates functional significance. 3

Guideline Recommendations

Current guidelines provide strong support for FFR use in intermediate stenoses:

  • FFR has a Class IIa recommendation (Level of Evidence A) for assessing angiographic intermediate coronary lesions (50-70% diameter stenosis) and guiding revascularization decisions in stable ischemic heart disease. 1
  • The 2021 ESC guidelines affirm that FFR is the current standard for functional assessment of lesion severity in patients with intermediate-grade stenosis (40-90%) without evidence of ischemia on non-invasive testing. 1
  • Revascularization of angiographically intermediate lesions without ischemia or without FFR <0.80 is not recommended (Class III recommendation, Level of Evidence B). 1

Complementary Role of IVUS

IVUS provides additional anatomic information that may be valuable in left main assessment:

  • IVUS is reasonable (Class IIa) for assessment of angiographically indeterminate left main CAD. 1
  • IVUS minimum lumen area (MLA) <2.8 mm² correlates with FFR <0.75 (sensitivity 79.7%, specificity 80.3%), though vessel size must be considered. 4
  • However, case reports suggest IVUS may reveal substantial narrowing even when FFR values fall in the gray zone (0.75-0.80), potentially prompting surgical revascularization. 5

Clinical Algorithm for Left Main Stenosis

When encountering intermediate left main stenosis (40-70% diameter):

  1. Measure FFR using a pressure wire during maximal hyperemia (adenosine-induced). 2

  2. If FFR ≤0.80: Proceed with revascularization, typically CABG given left main location. 3

  3. If FFR >0.80: Defer revascularization and manage medically with optimal medical therapy. 3

  4. If FFR 0.75-0.80 (gray zone): Consider IVUS for additional anatomic assessment, particularly if MLA <2.8 mm², which may favor revascularization despite borderline FFR. 4, 5

  5. Prescribe more intensive preventative therapy for patients with lower FFR values (even if >0.80), as prognosis worsens progressively with decreasing FFR. 1

Important Caveats

  • FFR data in patients with acute or recent myocardial infarction are limited, and established criteria should not be extended to this population. 2
  • In diffuse coronary disease with continuous pressure fall, FFR interpretation requires careful consideration. 2
  • The cross-sectional area of the 0.014-inch guide wire is <10% of minimal lumen area for intermediate lesions, allowing reliable gradient measurement. 2
  • Proper technique requires standardized pressure equalization and achievement of maximum hyperemia for quality assurance. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fractional Flow Reserve (FFR) in Angioplasty

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.